Strategies to prevent aortic complications in Marfan syndrome.

about

Strategies to prevent aortic complications in Marfan syndrome.

Item

http://www.wikidata.org/entity/Q42341364

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Strategies to prevent aortic complications in Marfan syndrome.

@en

Strategies to prevent aortic complications in Marfan syndrome.

@nl

type

Item

label

Strategies to prevent aortic complications in Marfan syndrome.

@en

Strategies to prevent aortic complications in Marfan syndrome.

@nl

prefLabel

Strategies to prevent aortic complications in Marfan syndrome.

@en

Strategies to prevent aortic complications in Marfan syndrome.

@nl

P1476

Strategies to prevent aortic complications in Marfan syndrome.

@en

P2093

Alberto Forteza

http://www.w3.org/2001/XMLSchema#string

Lucio Sartor

http://www.w3.org/2001/XMLSchema#string

P2860

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome.

Revised diagnostic criteria for the Marfan syndrome.

A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol.

Medical management of Marfan syndrome.

β-Blockers and angiotensin converting enzyme inhibitors: comparison of effects on aortic growth in pediatric patients with Marfan syndrome

Atenolol versus losartan in children and young adults with Marfan's syndrome.

Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaborat

The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis.

Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome.

P304

S434-S438

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/JTD.2017.04.69

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28616337

http://www.w3.org/2001/XMLSchema#string

P932

5462720

http://www.w3.org/2001/XMLSchema#string